Most people know Rener Gracie as the jiu-jitsu master who’s coached professional athletes, law enforcement, and military special forces.
But few know he was nearly sidelined by a devastating knee injury that could’ve ended his career.
While recovering from surgery, Rener became one of the 10,000+ patients treated with our first-generation APIC™ therapy — a biologic that concentrates a powerful natural protein and delivers it directly into damaged joints.
“My doctor said APIC could help prolong the life of my knee. I said: shoot it up.”
— Rener Gracie
The results? Life-changing.
So much so that Rener didn’t just become a patient — he became an investor and advocate.
Now, he’s stepping into the ring with us — helping to spread the word about CYT-108, our next-gen biologic therapy designed to be the first disease-modifying drug for osteoarthritis.
Rener’s story is about more than recovery.
It’s about empowerment. About flipping the script on Big Pharma.
And about backing a biotech company that’s not waiting for venture capital to make a move.
“What Cytonics is doing is unprecedented. This is grassroots medicine — and I’m all in.”
— Rener Gracie
👉 Join the movement. Invest now.
Until next time!
Joey Bose
President & CEO
Reg A Disclaimer
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. You may obtain a copy of the offering circular here.
